| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/19/2008 | CN101143885A Glucocorticoids derivative, preparation method and application thereof |
| 03/19/2008 | CN101143217A Treatment of neurological and neuropsychological disorders |
| 03/19/2008 | CN101143205A Traditional Chinese medicine for treating qi deficiency fever |
| 03/19/2008 | CN101143179A Traditional Chinese medicine for treating lumbato caused by lumbar muscle strain |
| 03/19/2008 | CN101143169A Traditional Chinese medicine preparation for curing peritoneal inflammation or pleural inflammation and its preparation method |
| 03/19/2008 | CN101143166A Medicine for swelling and relieving pain and its preparation method and application |
| 03/19/2008 | CN101143161A Medicinal composition for treating wounds and its preparation method |
| 03/19/2008 | CN101143138A Paracetamol and pseudoephedrine hydrochloride tablets made by dry powder direct tabletting |
| 03/19/2008 | CN100375750C Oligopolynucleotide of inhibiting activity of necrosin in human tumor |
| 03/19/2008 | CN100375630C Compound drop pills with flavescent sophora root and its preparation method |
| 03/19/2008 | CN100375616C Bone strengthening dripping pills with Premena fulva craib as raw material and method for preparing the same |
| 03/19/2008 | CN100375615C Compound drop pills of stramonium and its preparation method |
| 03/18/2008 | US7345151 Antagonists specific for denatured collagen and methods of using same |
| 03/18/2008 | US7345090 Galenical formulation |
| 03/18/2008 | US7345088 Synergistic mixtures |
| 03/18/2008 | US7345066 Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 03/18/2008 | US7345065 Using adrenergic receptors; side effect reduction |
| 03/18/2008 | US7345064 5-(4-pyridyl)valeric acid N-[2-(1-adamantyl)ethyl]-N-pentylamide; Autoimmune diseases such as rheumatoid arthritis, allergy and diabetes |
| 03/18/2008 | US7345063 Amides, preparation and therapeutic use as modulators of CCR-receptor activity |
| 03/18/2008 | US7345062 Substituted acylhydroxamic acids and method of reducing TNFαlevels |
| 03/18/2008 | US7345059 Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 03/18/2008 | US7345045 Pyrido-pyrimidine compounds as medicaments |
| 03/18/2008 | US7345041 Chemical compounds |
| 03/18/2008 | US7345040 Piperimido[1,2-a]piperazine-4,7diones derivatives; neurokinin (tachykinin) receptor antagonists; mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins; analgesic, neurodegenerative disorders, respiratory diseases, antiinflammatory agent, antidepressant |
| 03/18/2008 | US7345024 Pharmaceutical preparation, method for its production as well as its use |
| 03/18/2008 | CA2345248C Use of prostanoid antagonists for the treatment of primary headache disorders |
| 03/18/2008 | CA2329128C Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 03/18/2008 | CA2264739C Inhibition of nuclear transcription factor nf-kb by caffeic acid phenethyl ester (cape), derivatives of cape, capsaicin (8-methyl-n-vanillyl-6-nonenamide) and resiniferatoxin |
| 03/18/2008 | CA2219659C Rapamycin derivatives |
| 03/18/2008 | CA2167980C Cgrp antagonist used in a cosmetic composition; pharmaceutical or dermatologic composition produced |
| 03/18/2008 | CA2102494C A pharmaceutical composition containing a defined lipid system |
| 03/13/2008 | WO2008030466A1 Phthalazine, aza- and diaza-phthalazine compounds and methods of use |
| 03/13/2008 | WO2008029912A1 Compound having benzamide skeleton and cyclooxygenase (cox-1)-selective inhibitory activity |
| 03/13/2008 | WO2008029882A1 2-alkyl-6-(pyrazolopyridin-4-yl)pyridazinone derivative, addition salt thereof, and pde inhibitor comprising the derivative or the salt as active ingredient |
| 03/13/2008 | WO2008029877A1 Anti-aging agent, skin-whitening agent, anti-oxidative agent, and anti-inflammatory agent |
| 03/13/2008 | WO2008029829A1 Pyrazolopyridine derivative and phosphodiesterase (pde) inhibitor containing the same as active ingredient |
| 03/13/2008 | WO2008029825A1 Imidazole derivative |
| 03/13/2008 | WO2008029763A1 Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent |
| 03/13/2008 | WO2008029619A1 Ena antisense oligonucleotide having sequence-specific action |
| 03/13/2008 | WO2008029565A1 Compound having inhibitory activity on histone deacetylase, and pharmaceutical comprising the compound as active ingredient |
| 03/13/2008 | WO2008029237A2 Combination therapies for rheumatoid arthritis |
| 03/13/2008 | WO2008029199A1 Positively charged water-soluble prodrugs of n-arylanthranilic acids with very fast skin penetration rate |
| 03/13/2008 | WO2008028617A1 Heteroaryl derivatives as protein kinase inhibitors |
| 03/13/2008 | WO2007123939A8 Novel arylamino n-heteraryls as mek inhibitors |
| 03/13/2008 | WO2007092065A3 Compounds and compositions as lxr modulators |
| 03/13/2008 | WO2007073505A3 Trpa1 inhibitors for treating pain |
| 03/13/2008 | US20080064753 Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators |
| 03/13/2008 | US20080064751 Utilizing lipoxin analogs; polyisoprenyl phosphate signaling inhibition |
| 03/13/2008 | US20080064747 Prevention of Neutrophil Recruitment |
| 03/13/2008 | US20080064746 Lipoxins and Aspirin-Triggered Lipoxins and Their Stable Analogs in the Treatment of Asthma and Inflammatory Airway Diseases |
| 03/13/2008 | US20080064731 Remedy for chronic disease |
| 03/13/2008 | US20080064720 Very Late Antigen-4 dependent inflammatory disease; asthma, allergic rhinitis, sinusitis, conjunctivitis, food allergy, inflammatory skin disorders, autoimmune disorders, or atherosclerosis, inflammatory skin disorder; methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-hydroxy-2-propenoate |
| 03/13/2008 | US20080064719 Crf Receptor Antagonists And Methods Relating Thereto |
| 03/13/2008 | US20080064707 Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 03/13/2008 | US20080064695 Neuronal nicotinic acetylcholine receptor modulators; such as ethyl 1-[4-(aminosulfonyl)phenyl]-5-(4-bromophenyl)-2-methyl-1H-pyrrole-3-carboxylate |
| 03/13/2008 | US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea |
| 03/13/2008 | US20080064686 Programmed cell death, autoimmunity, inflammation, hyperproliferation; easy formulation, shelf life |
| 03/13/2008 | US20080064672 Compositions containing topical active agents and pentyleneglycol |
| 03/13/2008 | US20080064660 Modulation of Inflammation Related to Columnar Epithelia |
| 03/13/2008 | US20080064640 Particularly drugs and cosmetic agents; ethoxylated meadowform oil having between 10 and 19 ethoxy units, and the delivered agent, especially analgesics, antiinflammatory agents or antiwrinkle agents; improved penetration and bioavailability |
| 03/13/2008 | US20080064637 Before cardiopulmonary bypass surgery or coronary artery bypass grafting; injecting a polypeptide preferential inhibitor of kallikrein, rather than aprotinin |
| 03/13/2008 | US20080064633 Preventing fibronectin deposition and fibrosis; phospholipase A2 inhibition; cystic fibrosis |
| 03/13/2008 | US20080063736 Composition Having Effect Of Moxibustion And Press Pellet Using The Same |
| 03/13/2008 | US20080063646 variable heavy chain amino acid sequence of SEQ ID NO. 50 and a variable light chain amino acid sequence of SEQ ID NO. 48, designated herein as HuAIP12 |
| 03/13/2008 | US20080060645 Dry Powder Inhalant Composition |
| 03/13/2008 | CA2663100A1 Indazole derivatives as modulators of interleukin-1 receptor-associated kinase |
| 03/13/2008 | CA2662112A1 Imidazole derivatives and their use as cannabinoid type 2 (cb2) receptor modulators |
| 03/13/2008 | CA2662031A1 Heteroaryl derivatives as protein kinase inhibitors |
| 03/13/2008 | CA2661992A1 Pyrazolopyridine derivative and phosphodiesterase (pde) inhibitor containing the same as active ingredient |
| 03/12/2008 | EP1897950A2 Human GIL-19/AE289 proteins and polynucleotides encoding same |
| 03/12/2008 | EP1897880A1 1,3-benzothiazinone derivative and use thereof |
| 03/12/2008 | EP1897870A1 Pharmaceutical composition comprising 2-pyridone derivative as active ingredient |
| 03/12/2008 | EP1897555A2 Supplemented OMV vaccine against meningococcus |
| 03/12/2008 | EP1897551A1 Health food and pharmaceutical composition for amelioration of disease induced by metabolic disorder in cartilage |
| 03/12/2008 | EP1896453A1 Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists |
| 03/12/2008 | EP1896438A1 Phenyl-pyrazole derivatives as non-steroidal glucocorticoid receptor ligands |
| 03/12/2008 | EP1896424A2 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF |
| 03/12/2008 | EP1896077A2 Methods and compositions for the prevention and treatement of inflammatory disease |
| 03/12/2008 | EP1896072A2 A direct drug delivery system based on thermally responsive biopolymers |
| 03/12/2008 | EP1896053A1 Pharmaceutical composition comprising fgf18 and il-1 antagonist and method of use |
| 03/12/2008 | EP1896042A2 Methods and reagents for the treatment of inflammatory disorders |
| 03/12/2008 | EP1896036A1 Anti-inflammatory agents |
| 03/12/2008 | EP1896031A1 Thiazolopyrimidines for use in therapy |
| 03/12/2008 | EP1896015A1 Methods and compositions for the treatment of autoimmune and inflammatory diseases associated with toll-like receptors |
| 03/12/2008 | EP1896014A2 Chemical compounds |
| 03/12/2008 | EP1896012A2 Anti-inflammatory agents |
| 03/12/2008 | EP1895947A2 Improved method of treating degenerative spinal disorders |
| 03/12/2008 | EP1745780A4 Medicinal preparation |
| 03/12/2008 | EP1663993B1 Guanidine derivatives |
| 03/12/2008 | EP1581229B1 Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 03/12/2008 | EP1539693B1 Cannabinoid receptor agonists |
| 03/12/2008 | EP1495009B1 Cyanamides useful as reversible inhibitors of cysteine proteases |
| 03/12/2008 | EP1414809B1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 03/12/2008 | EP1408999B1 Compositions addressing inflammation and/or degenerative disorders |
| 03/12/2008 | EP1307194B1 Fentanyl composition for nasal administration |
| 03/12/2008 | EP1265648B1 NOVEL collagen-BASED MATERIAL WITH IMPROVED PROPERTIES FOR USE IN HUMAN AND VETERINARY MEDICINE AND THE METHOD OF MANUFACTURING SUCH |
| 03/12/2008 | EP1210434B1 Mammalian interleukin-12 p40 and interleukin b30. combinations thereof. antibodies. uses in pharmaceutical compositions |
| 03/12/2008 | EP0876487B1 Mammalian cx3c chemokine genes |
| 03/12/2008 | EP0614374B2 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 03/12/2008 | CN201033171Y Medicine label for treating arthralgia |